Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2001Clinical Infectious DiseasesOpen Access

A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

RAR. AllyUniversity of PretoriaDSDirk SchürmannHumboldt-Universität zu BerlinWKWolfgang KreiselUniversity of Freiburg

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ally et al. (2001) studied this question.

synapsesocial.com/papers/6a7cb3ecdd332b0104190748https://doi.org/10.1086/322653
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Oral Azole Drugs as Systemic Antifungal Therapy1994 · 598 citations
  2. 2Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patientsreceiving long-term continuous versus intermitent fluconazole therapy1996 · 57 citations
  3. 3Invasive Pulmonary Infection Due to Scedosporium apiospermum in Two Children with Chronic Granulomatous Disease1998 · 128 citations
  4. 4Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia1997 · 165 citations
  5. 5Resistance of Candida species to fluconazole1995 · 880 citations